Acute myeloid leukemia: Clinical Practice Guidelines in Oncology Review uri icon

Overview

MeSH Major

  • Antineoplastic Agents
  • Hematopoietic Stem Cell Transplantation
  • Leukemia, Myeloid

abstract

  • Approximately 11,960 people will be diagnosed with acute myeloid leukemia (AML) in 2005, and 9,000 patients will die of the disease. As the population ages, the incidence of AML, along with myelodysplasia, appears to be rising. Equally disturbing is the increasing incidence of treatment-related myelodysplasia and leukemia in survivors of tumors of childhood and young adulthood such as Hodgkin's disease, sarcomas, breast and testicular cancers, and lymphomas. Recent large clinical trials have highlighted the need for new, innovative strategies because outcomes for AML patients, particularly older patients, have not substantially changed in the past 3 decades. © Journal of the National Comprehensive Cancer Network.

publication date

  • January 2006

Research

keywords

  • Review

Identity

Language

  • eng

PubMed ID

  • 16403402

Additional Document Info

start page

  • 16

end page

  • 36

volume

  • 4

number

  • 1